‘Contingency on contingency’: Judge won’t halt IP dispute over Abilify generic

Intellectual Property 2024-11-01 11:18 pm By Sam Matthews | Melbourne

The Commonwealth has lost its bid to pause a long-running dispute over a generic form of brand drug Abilify while the High Court hears a different generic drug battle.